Warnex Receives Funding From Northern Ontario Heritage Fund Corporation
News Dec 15, 2009
Warnex Inc. announced that its subsidiary Warnex PRO-DNA Services Inc., located in Thunder Bay, Ontario, is the recipient of funding from the Northern Ontario Heritage Fund Corporation (NOHFC) for the development of a forensics database, based on mitochondrial DNA, in collaboration with the Paleo-DNA Laboratory of Lakehead University.
"Mitochondrial DNA testing is a powerful tool being used to solve criminal cases, including cold cases, as well as to prove wrongful convictions," said Mark Busgang, President and CEO of Warnex.
"We appreciate the opportunity that this funding from the Ontario government will create and we are pleased to collaborate with Lakehead University to solidify our presence as two of the world's leading mitochondrial DNA testing laboratories."
Warnex PRO-DNA Services and the Paleo-DNA Laboratory of Lakehead University are the only two laboratories accredited in Canada for mitochondrial DNA testing.
With this funding, they will develop the MitoNorth Database, the first mitochondrial DNA database in Canada, which will be used by law enforcement and legal professionals to prevent individuals from being falsely accused and help prosecute criminals. The two laboratories received a total of $676,100 in funding from NOHFC for the development of the MitoNorth Database.
Changing Lanes: Algorithm Helps AI Drive More Like HumansNews
For self-driving cars, algorithms for changing lanes are beset by one of two problems. Either, they rely on detailed statistical models of the driving environment, which are too complex to analyze on the fly; or they’re so simple that they can lead to impractically conservative decisions, such as never changing lanes at all. Now a new algorithm hopes to split the difference, allowing aggressive lane changes than the simple models do but relies only on immediate information about other vehicles’ directions and velocities to make decisions.
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018